Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins

Molecular Therapy

Volumn 4, Issue 2, 2001, Pages 149-156

  Desmaris, Nathalie ^a   Bosch, Assumpcio ^a   Salaün, Christine ^a   Petit, Caroline ^a   Prévost, Marie Christine ^b   Tordo, Noël ^c   Perrin, Pierre ^c   Schwartz, Olivier ^a   De Rocquigny, Hugues ^a   Heard, Jean Michel ^a  

^a CNRS   (France)

^b Laboratoire De Microscopie lectronique   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Central nervous system; Lentivirus vector; Mokola; Neuronal tropism; Rabies virus; Retrograde axonal transport; VSV G

Indexed keywords

BETA GALACTOSIDASE; GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN TISSUE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG MANUFACTURE; DRUG TRANSPORT; ELECTRON MICROSCOPY; EMBRYO; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; LENTIVIRINAE; MOUSE; NERVE CELL; NEUROTROPISM; NONHUMAN; NOSE CAVITY; PERIKARYON; RABIES; RABIES VIRUS; RAT; RETROGRADE NERVE FIBER TRANSPORT; RHABDOVIRUS; SMELLING; STRIATE CORTEX; SUSPENSION; SYNCYTIUM; TITRIMETRY; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS INFECTIVITY; VIRUS TYPING;

EID: 17944376248     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0431     Document Type: Article

References (48)

1. Retrovirus envelope glycoproteins
2. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic and polytropic murine leukemia viruses
3. Packaging system for rapid production of murine leukemia virus vectors with variable tropism
4. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
5. Retrovirus vectors bearing jaagsiekte retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3
6. TM domains swapping of MuLV and HTLV envelopes confer different infectious abilities despite similar incorporation into virions
7. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4- lymphoid cells
8. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4- cells
9. Truncation of the human immunodeficiency virus type 2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles
10. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very hight titer and efficient gene transfer into mammalian and non mammalian cells
11. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus
12. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus
13. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins
14. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
15. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retrovirus
16. Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein
17. In vivo gene delivery and stable transduction of non dividing cells by a lentiviral vector
18. Transduction of nondividing cells using a pseudotypes defective high-titer HIV type 1 particles
19. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
20. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
21. Pseudotyping HIV-1 by the glycoprotein of VSV targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A
22. Cytosolic Gag p24 as an index of productive entry of human imunodeficiency virus type 1
23. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector
24. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector
25. Evidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity
26. Binding of rabies virus to purified Torpedo acetylcholine receptor
27. The neuronal cell adhesion molecule is a receptor for rabies virus
28. Low-affinity nerve-growth factor receptor (p75NTR) can serve as a receptor for rabies virus
29. Rabdoviruses: Rabies
30. Rabies glycoprotein is a trimer
31. Low-pH induced conformational changes in viral fusion proteins: Implications for the fusion mechanism
32. Homology between the glycoproteins of vesicular stomatitis virus and rabies virus
33. High-titer human immunodeficiency virus type-1-based vector systems for gene delivery into non dividing cells
34. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles
35. Stable gene transfer to the nervous system using a non-primate lentivirus vector
36. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors
37. The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly
38. Involvement of gangliosides in rabies virus infection
39. Separable mechanisms of attachment and cell uptake during retrovirus infection
40. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system
41. Reproduction of lyssaviruses: Ultrastructure composition of lyssaviruses and functional aspects of pathogenesis
42. Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein
43. Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation
44. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses
45. Reversal of pathology in the entire brain of mucoploysaccharidosis type VII mice after lentivirus-mediated gene transfer
46. Structure and expression in baculovirus of the Mokola virus glycoprotein: An efficient recombinant vaccine
47. Chimeric lyssavirus glycoproteins with increased immunological potential
48. Murine mucopolysaccharidosis type VII. Characterization of a mouse with β-glucuronidase deficiency